Manjunath Vadmal is a Dermatology physician affiliated with University of Southern California. OpenAlex indexes 48 publications with 778 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2720 W Magnolia Blvd
Burbank, CA 915053034
Telephone
818-842-8000Provider last certified this registry record 31 Dec 2019.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year202520 payments
- Novartis Pharmaceuticals CorporationProgram year202518 payments
- Galderma Laboratories, L.P.Program year202538 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
41.7%Corticosteroid27.6%Triamcinolone acetonide72%Triamcinolone Acetonide19%Desoximetasone7%Fluocinolone Acetonide2%Part D + Part B<11 patientsRetinoid3.2%Tazarotene45%Adapalene31%Acitretin23%Part D<11 patients+ 7 more classes in this area
Anti-infectives
20%Azole Antifungal12.8%Ketoconazole100%Part D≥139 patientsTetracycline-class Drug3.8%Doxycycline Hyclate79%Minocycline Hcl21%Part D<11 patients+ 2 more classes in this area
Sensory organs
17.6%Corticosteroid17.6%Clobetasol Propionate44%Betamethasone Diprop Augmented37%Desonide19%Part D≥105 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Primary cutaneous adenomyoepithelioma.
PubMed
2012 - Complex adnexal tumours of the skin: a report of three cases and review of literature
Journal of Clinical Pathology
2012 - Major blunders by noted pathologists.
PubMed
2012
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”